Given 2 Years, Living 13 Strong
Living 13 Years Strong: Debbie’s Stage 4 Lung Cancer Journey of Hope and Persistence
When Debbie was first diagnosed with stage 4 lung cancer, doctors told her she might only have one to two years left. Like many patients, she felt overwhelmed and afraid. But instead of giving up, she sought a second opinion and learned that her cancer carried the BRAF mutation. This discovery opened the door to targeted therapy through a clinical trial—something that gave her options beyond traditional chemotherapy and radiation.
Over the last 13 years, Debbie has faced many treatments, side effects, and setbacks, but also many breaks from therapy where she could live life more fully. She has outlived the predictions and now encourages other patients to stay hopeful, ask questions, and keep pushing for answers. Debbie’s story shows how advances in biomarker testing and targeted therapy can turn what once felt like an “end date” into years filled with milestones and new memories.
Her journey reminds us that no one is defined by statistics. For patients with advanced lung cancer, Debbie is living proof that hope, persistence, and medical progress can lead to more time and better quality of life. (Source: GO2 for Lung Cancer)
Safer Cancer Drug Dosing Ahead
Safer Cancer Drug Dosing: ASCO and FDA Push for Optimal, Not Maximum, Doses
Concerns are growing that cancer drugs may be given at higher doses than patients actually need, leading to unnecessary side effects and treatment interruptions. The American Society of Clinical Oncology (ASCO), working with the FDA, has issued new principles urging a shift from the old “maximum tolerated dose” approach toward finding the “optimal effective dose.” This matters for newer treatments like immunotherapies and targeted therapies, where higher doses don’t always improve results but often increase harmful side effects. Patient surveys show many people with advanced cancers struggle with severe treatment side effects, and oncologists frequently lower doses early on to help patients stay on therapy.
To fix this, ASCO recommends designing trials that test multiple dosage levels, tailoring studies to real-world patients, and improving how patient-reported side effects are tracked. These steps align with the FDA’s Project Optimus, which is pushing for better drug dosing in cancer research. For patients, this shift offers hope for treatment that works just as well—or better—while being easier to tolerate, helping people with advanced cancer focus on living fully instead of fighting side effects. (Source: Oncology News Central)
Read the complete article here >
New Clues on How Cancer Spreads
New Clues on Cancer Metastasis: How “Shape-Shifting” Cells Spread and Survive
For decades, doctors have known that cancer’s deadliest threat comes not from the original tumor but from metastasis — when cancer spreads to other parts of the body. Up to 90% of cancer deaths are linked to this process. Now, researchers led by Dr. Joan Massagué at Memorial Sloan Kettering are uncovering important insights into how metastatic cells survive, hide, and return to grow new tumors years later. These “shape-shifting” cells act like stem cells, traveling back in time to earlier, more flexible states that allow them to adapt and resist treatment. They can also slip into dormancy, hiding from the immune system until the conditions are right to awaken and spread again.
Scientists are learning that metastatic cells use different strategies depending on the type of cancer and the organ they invade. They can even change their physical shape to avoid being destroyed by the immune system. These discoveries open new possibilities for treatment — from targeting the hidden “time traveler” state, to waking dormant cells so the immune system can attack them, to blocking proteins that allow cancer cells to evade detection. While challenges remain, Dr. Massagué emphasizes that metastasis is no longer an automatic death sentence. With advances in immunotherapy and targeted research, controlling — and in some cases curing — stage 4 cancer is becoming more possible than ever before. (Source: Memorial Sloan Kettering)
Future of Cancer Screening Shows Hope
Future of Cancer Screening: Multi-Cancer Early Detection Brings New Hope
Most cancers are still found late because only five types—colon, cervical, breast, lung, and prostate—have routine screening. A new direction called multi-cancer early detection (MCED) aims to spot cancers with a single test. Instead of hunting for tiny, hard-to-find tumor DNA fragments in the blood, researchers are building tiny “sensors” that circulate in the body and switch on when they meet enzymes made by early cancer cells. These sensors release a synthetic marker that shows up clearly in samples like urine, creating a much stronger, earlier signal than traditional tests in preclinical studies.
Why it matters: this approach could make screening simpler, more accurate, and more accessible—potentially even via low-cost strips for clinics with limited resources—and may help catch hard-to-find cancers (including lung cancer) sooner, when treatment works best. Logic-based sensor designs (think an “AND” gate requiring multiple cancer signals) may reduce false alarms, and early clinical use could include tracking treatment response or watching for recurrence. Safety testing is still ahead, but progress is rapid. If successful, MCED could shift many diagnoses from late-stage to early-stage—and offer hope and options for people living with or at risk for advanced disease. (Source: MIT Technology Review)
Read the complete article here >
Yoga, Meditation, and More Bring Relief
Yoga, Meditation, and Integrative Medicine Ease Cancer Treatment Side Effects
A new clinical trial shows that live, online classes in yoga, meditation, tai chi, and fitness can do more than just help patients feel calmer — they can actually reduce the side effects of cancer treatment. Patients who joined these virtual integrative medicine sessions during chemotherapy, radiation, immunotherapy, or targeted therapy reported less fatigue, anxiety, depression, and trouble sleeping. Remarkably, they also needed fewer hospital stays, and when they were admitted, their time in the hospital was much shorter.
This approach, offered through Memorial Sloan Kettering’s Integrative Medicine at Home program, costs $25 per month and is available to patients anywhere — not just those treated at MSK. Many patients find the classes give them both physical strength and emotional support by connecting with others going through cancer. Other services like acupuncture and music therapy can also play a role in making treatment more tolerable. Research continues to grow, with hopes of expanding access nationwide. For patients and caregivers, these integrative therapies provide a safe, evidence-based way to feel stronger and more supported throughout cancer treatment. (Source: Memorial Sloan Kettering)
Riding Through Cancer: Christy’s Story
Riding My Harley Through Cancer: Christy’s Stage 4 Lung Cancer Story
When Christy Erickson was diagnosed with stage IV lung cancer at just 41, she feared she wouldn’t see her children grow up. But after months of unanswered questions and second opinions, genetic testing revealed her tumor carried an EGFR mutation—opening the door to a targeted therapy called osimertinib. This treatment, born from years of research, gave her what once seemed impossible: more time with her family and the chance to live fully, not just survive.
Christy has faced her journey with courage, faith, and determination. She’s checked off bucket-list dreams, from riding her own Harley to competing in strongman events, and she shares her story to encourage others to advocate for themselves. “Osimertinib gave me time,” she says—time to see her daughter graduate, time to rediscover joy, and time to inspire other patients that even after a stage IV diagnosis, hope and healing are possible. (Source: Winship Cancer Institute of Emory University)
Second Opinions Can Save Lives
Why Getting a Second Opinion for Cancer Can Save Your Life
Being told you have cancer is overwhelming, and it’s easy to feel pressured to start treatment right away. But getting a second opinion can make a huge difference—it may confirm the diagnosis, catch mistakes, or suggest new treatment options. For patients with stage 4 or hard-to-treat lung cancer, this extra step can open the door to advanced therapies and clinical trials not available everywhere.
Specialists at National Cancer Institute-designated centers look deeper than a single test. They review scans, biopsy slides, and genetic testing to match you with the best targeted therapy or immunotherapy. Many doctors welcome second opinions, and sometimes both teams can work together—giving you more support, not less.
Most importantly, a second opinion can give you peace of mind. Knowing your diagnosis and plan have been double-checked helps you move forward with confidence and focus on what matters most: your care and your life. (Source: Winship Magazine)
Read the complete article here >
Genetics Study Brings Lung Cancer Hope
A powerful new genetics study is offering fresh hope in the fight against lung cancer — especially for patients with rare mutations and those who’ve never smoked. The Lung Cancer Genetics Study, launched in 2024 by 23andMe and supported by nearly two dozen patient advocacy groups, is collecting genetic and clinical data from thousands of lung cancer patients to help uncover what drives this complex disease. It’s one of the first efforts of its kind to truly center patient voices from the beginning, ensuring that research reflects real-world experiences.
The project began with a friendship between two women living with lung cancer, Ilana Stromberg and Susan Troper Wojcicki, both mothers of five and determined to make a difference. Motivated by the lack of research and funding for lung cancer, especially RET-positive and other biomarker-driven subtypes, they envisioned a national lung cancer registry that could drive discoveries and lead to better, more personalized treatments. Susan’s passing in 2024 makes the study even more meaningful to those involved. Her legacy lives on through this groundbreaking initiative, which is expected to accelerate research and give families facing lung cancer a renewed sense of hope. (Source: 23andMe Blog)
FIBER It Does a Body Good
Fiber and Cancer Prevention: Why It Matters
Should you be eating more fiber to help prevent cancer? And how much do you really need to reduce your risk?
It could be time for a fiber tune-up of your diet. Most American adults get only half the recommended daily dose, according to the Centers for Disease Control and Prevention (CDC).
Clinical dietitian-nutritionist Cara Anselmo, MS, RDN, is an expert in breast cancer nutrition and is a certified specialist in obesity and weight management.
“Eating more fiber is often overlooked as one of the healthiest things we can do for ourselves,” Anselmo says.
Fiber not only improves heart health, reduces diabetes risk, and aids in weight control, it may reduce the risk of several common cancers such as colorectal cancer.
How Does Fiber Reduce the Risk of Colorectal Cancer?
Dietary fiber has long been linked to a lower risk of certain types of cancer, particularly colorectal cancer. Colon cancer rates are increasing among young adults. Because less than 10% of adults are getting enough fiber, scientists think this trend may be connected.
One of the main ways that fiber helps to protect against colon cancer, according to Anselmo, is by fostering a healthy population of bacteria in the colon, known as the microbiome. Fiber remains in the colon after other components of the diet become absorbed by the body.
“When fiber is fermented by the bacteria in our colon,” Anselmo says, “it produces metabolites, which reduce inflammation and protect the colon cells from becoming cancerous. These metabolites can also activate our immune system and increase anti-cancer immunity.”
Fiber also has several other effects that improve our metabolic health, which indirectly lowers the risk of several cancers. For example, fiber can increase the speed at which food passes through the gut, which can lower absorption and exposure time to less healthy foods we may have consumed. Fiber can also lower cholesterol levels.
What Is a High-Fiber Diet?
A high-fiber diet means you eat foods that are rich in this type of carbohydrate, found mainly in plant foods such as fruits, vegetables, whole grains, beans, peas, and legumes. Consuming more than 25 to 30 grams of fiber per day is generally considered to be a high-fiber diet.
What Are the Kinds of Fiber?
There are two main types of dietary fiber — soluble and insoluble. Both types of fiber are healthy and can lower cancer risk.
Soluble fiber attracts water into the intestines and becomes a gel. It can help lower blood sugar and cholesterol levels. Foods higher in soluble fiber include:
• Oats
• Beans
• Citrus fruits
• Peas
Insoluble fiber doesn’t dissolve in water. It can help move food through your digestive system, absorb water to provide bulk, and may help prevent constipation. Foods higher in insoluble fiber include:
• Whole grains
• Some vegetables
• Nuts and seeds
How Much Fiber Do You Need?
The MSK registered dietitian-nutritionist team recommends that most people eat 25 grams of fiber per day. “Consume half of your fiber from whole foods like whole grains, vegetables, and beans,” Anselmo advises. “Fiber-supplemented products are not as effective as whole foods and may not have additional nutrients that help you reach your optimal health.”
Anselmo also stresses the importance of staying well hydrated when increasing dietary fiber in order to minimize potential symptoms such as bloating and abdominal discomfort as your gastrointestinal tract adapts to new changes. She reminds patients to always ask their cancer care team if they should follow any special diet before, during, or after treatment.
How Is MSK Researching the Role of Fiber and Cancer?
Studies are underway to help determine a person’s optimal dose of fiber to prevent cancer, based on their biology, genetics, and lifestyle.
MSK is also investigating which bacteria are involved in fermenting fiber into the metabolites that protect against various cancers, including breast, skin, prostate, colon, and rectal cancer. If scientists can identify a specific bacterial signature, other interventions such as bacterial transplants may work to reduce cancer risks.
Finally, there are ongoing studies testing whether fiber intake and certain probiotic compounds might enhance the effectiveness of chemotherapy and immunotherapy. (Source: Memorial Sloan Kettering News- 2025, Issue 1)
Resources for Living With Stage 4 Cancer
Learn more about topics like fiber and cancer prevention, along with other important aspects of living with Stage 4 cancer. Become a member of our community to receive inspiring stories, helpful resources, and updates on how we support individuals and families facing advanced-stage cancer. Stay informed with the latest research and gain early access to educational content.
Boosting Cancer Immunity Through Fasting
Fasting and Cancer Immunity Explained
How Fasting May Supercharge the Immune System to Better Fight Cancer…
More than a dozen types of cancer are sensitive to obesity, which can cause inflammation that damages cells, increased hormone levels, and other changes. So it makes sense for researchers to explore whether fasting to slow body fat and improve metabolic health might improve outcomes.
Now laboratory researchers at Memorial Sloan Kettering Cancer Center (MSK) and their collaborators have found that fasting can SUPERCHARGE the immune system’s “natural killer” cells. (Natural killer cells, or NK cells, for short, are a type of white blood cell that can kill abnormal or damaged cells, such as cancer cells.)
Fasting can reprogram the metabolism of natural killer cells, the team found in a study of mice. Those reprogrammed cells are better able to survive in the harsh environment in and around tumors. Their cancer-fighting ability is stronger, too.
The research, which was published in Immunity — one of the top immunology journals — explains how natural killer cells get reprogrammed during periods of fasting. The researchers are optimistic that what they’re learning in animal models could help make human immunotherapies more effective in people.
“Tumors are very hungry,” says immunologist Joseph Sun, PhD, the study’s senior author. “They use up the essential nutrients flowing to normal tissue. In that nutrient-starved environment, it is harder for natural killer cells to survive, so their function is impaired. Fasting reprograms these natural killer cells to better survive in this suppressive environment.”
What Are Natural Killer Cells?
Natural killer cells get their name because they can destroy a threat without having to recognize that threat — unlike other immune cells, called T cells, which require exposure to a specific threat in order to target it.
In general, the more NK cells that are present within a tumor, the better the prognosis is for the patient.
How Fasting Reprograms and Redistributes NK Cells
For the study, mice with cancer were fasted for 24 hours twice a week and then allowed to eat freely in between fasts. While the mice did not lose weight, the fasting had a profound effect on their natural killer immune cells.
Just as happens in humans, fasted mice saw a drop in their glucose levels and a rise in free fatty acids, which are lipids released by fat cells.
“During each of these fasting cycles, NK cells learned to use these fatty acids as an alternative fuel source to glucose,” says study first author Rebecca Delconte, PhD, a postdoctoral fellow in the Sun Lab. “This really improves their response against cancer and helps them survive in the harsh environment around the tumor.”
Fasting also led NK cells to travel to and interact with different parts of the body in big numbers. Many of the NK cells travel into the bone marrow, where they are programmed to develop a more powerful response against cancer. Meanwhile, NK cells that travel to the spleen undergo a separate reprogramming, making them better able to use lipids as a fuel source.
“With both of these mechanisms put together, we find that NK cells will move to the tumor and be primed to better kill the cancer cells,” Dr. Delconte says. “They’re more able to survive in this harsh environment, and their power is strengthened against cancer cells.”
Potential To Improve Cancer Treatments
There are several potential opportunities to advance the mouse-model research toward treating patients in the clinic, the researchers say.
First, clinical trials are already beginning to study the safety and effectiveness of fasting in combination with standard treatments. Another avenue would be to identify drugs that could mimic the underlying mechanisms without requiring patients to fast. Third, small molecules might be able to be put into a pill and taken outside of the body and then administered back to patients to improve treatment effects.
Right now, however, more clinical data is still needed about the effects of fasting for people with cancer, MSK researchers say.
There are many different types of fasting, and some might be helpful while others might be harmful. Patients should speak with their doctors about what’s safe and healthy for their individual situation. (Source: Memorial Sloan Kettering News- 2025, Issue 1)
Resources for Living With Stage 4 Cancer
Learn more about topics like fasting and cancer immunity, along with other important aspects of living with Stage 4 cancer. Become a member of our community to receive inspiring stories, helpful resources, and updates on how we support individuals and families facing advanced-stage cancer. Stay informed with the latest research and gain early access to educational content.
Hope from Metastasis Research
Metastasis is when cancer spreads from the original tumor to other parts of the body, and it’s often the toughest part to treat. Researchers at Memorial Sloan Kettering are studying how these metastatic cancer cells change and adapt to survive treatments. They found that metastatic cells can “shift” their identity to better survive, which helps explain why they become harder to stop over time.
At MSK, doctors are creating patient-based 3D models to better understand lung cancer spread and to test how different treatments work. There’s also a clinical trial exploring a drug that stops cancer cells in the brain and spine from stealing iron, which they need to grow and to avoid immune attack. This research is paving the way toward treatments that are more targeted and personalized.
For patients with late-stage or metastatic cancer, these advances offer hope for longer control of the disease and, one day, new ways to stop metastasis altogether. (Source: Memorial Sloan Kettering)
Cancer Vaccines Offer New Hope
Cancer vaccines, once considered a distant dream, are becoming a hopeful reality thanks to groundbreaking research inspired by the success of COVID-19 mRNA vaccines. Unlike traditional vaccines designed to prevent illnesses, therapeutic cancer vaccines teach the body’s own immune system how to recognize and attack cancer cells. Memorial Sloan Kettering (MSK) researchers, building on ideas first imagined over a century ago, have significantly advanced these vaccines. Dr. David Scheinberg, a leading researcher at MSK, explains that new technologies now allow vaccines to target multiple proteins specific to cancer cells, making treatments more effective and reducing side effects compared to chemotherapy and radiation.
One promising area is personalized mRNA cancer vaccines, custom-made for each patient based on their tumor’s unique characteristics. Early trials, particularly in pancreatic cancer, have shown encouraging results, with vaccinated patients’ immune cells remaining active for years. Additionally, MSK researchers are developing off-the-shelf vaccines targeting common cancer markers, such as WT1, found in leukemia and ovarian cancer. These vaccines could soon offer accessible, affordable options for many patients. The rapid progress in cancer vaccine development at MSK offers genuine optimism, especially for patients fighting advanced or hard-to-treat cancers. (Source: Memorial Sloan Kettering)
Read the complete article here >
